HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-counterfeiting bill introduced in House

This article was originally published in The Rose Sheet

Executive Summary

A bi-partisan bill that would provide additional anti-counterfeiting tools to law enforcement has been introduced in the House of Representatives, bill's sponsors announce Dec. 5. Co-sponsored by Reps John Conyers, D-Mich., and Lamar Smith, R-Texas, the legislation strengthens the civil and criminal laws relating to copyright and trademark infringement, establishes the Office of the U.S. Intellectual Property Enforcement Representative, provides for the appointment of intellectual property officers to work with foreign countries to combat counterfeiting, authorizes the creation of an IP division in the Justice Department and gives the Justice Department additional resources to improve IP law enforcement. Sponsors of the bill estimate lost sales and jobs associated with counterfeiting and piracy in the U.S. reach $200 bil.-$250 bil. per year, with global impact around $600 bil. annually...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel